5jsi: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 3: | Line 3: | ||
<StructureSection load='5jsi' size='340' side='right'caption='[[5jsi]], [[Resolution|resolution]] 2.00Å' scene=''> | <StructureSection load='5jsi' size='340' side='right'caption='[[5jsi]], [[Resolution|resolution]] 2.00Å' scene=''> | ||
== Structural highlights == | == Structural highlights == | ||
<table><tr><td colspan='2'>[[5jsi]] is a 2 chain structure with sequence from [ | <table><tr><td colspan='2'>[[5jsi]] is a 2 chain structure with sequence from [https://en.wikipedia.org/wiki/Candidatus_Actinomarina_minuta Candidatus Actinomarina minuta]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5JSI OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5JSI FirstGlance]. <br> | ||
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=IOD:IODIDE+ION'>IOD</scene>, <scene name='pdbligand=LFA:EICOSANE'>LFA</scene>, | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=IOD:IODIDE+ION'>IOD</scene>, <scene name='pdbligand=LFA:EICOSANE'>LFA</scene>, <scene name='pdbligand=LYR:N~6~-[(2Z,4E,6E,8E)-3,7-DIMETHYL-9-(2,6,6-TRIMETHYLCYCLOHEX-1-EN-1-YL)NONA-2,4,6,8-TETRAENYL]LYSINE'>LYR</scene>, <scene name='pdbligand=OLC:(2R)-2,3-DIHYDROXYPROPYL+(9Z)-OCTADEC-9-ENOATE'>OLC</scene></td></tr> | ||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5jsi FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5jsi OCA], [https://pdbe.org/5jsi PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5jsi RCSB], [https://www.ebi.ac.uk/pdbsum/5jsi PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5jsi ProSAT]</span></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | |||
</table> | </table> | ||
== Function == | |||
[https://www.uniprot.org/uniprot/S5DM51_9ACTN S5DM51_9ACTN] | |||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 24: | Line 25: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Candidatus | [[Category: Candidatus Actinomarina minuta]] | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
[[Category: Gordeliy | [[Category: Gordeliy V]] | ||
[[Category: Gushchin | [[Category: Gushchin I]] | ||
[[Category: Kovalev | [[Category: Kovalev K]] | ||
[[Category: Melnikov | [[Category: Melnikov I]] | ||
[[Category: Polovinkin | [[Category: Polovinkin V]] | ||
[[Category: Popov | [[Category: Popov A]] | ||
[[Category: Shevchenko | [[Category: Shevchenko V]] | ||
Latest revision as of 10:39, 8 March 2023
Structure of membrane proteinStructure of membrane protein
Structural highlights
FunctionPublication Abstract from PubMedWe describe a fast, easy, and potentially universal method for the de novo solution of the crystal structures of membrane proteins via iodide-single-wavelength anomalous diffraction (I-SAD). The potential universality of the method is based on a common feature of membrane proteins-the availability at the hydrophobic-hydrophilic interface of positively charged amino acid residues with which iodide strongly interacts. We demonstrate the solution using I-SAD of four crystal structures representing different classes of membrane proteins, including a human G protein-coupled receptor (GPCR), and we show that I-SAD can be applied using data collection strategies based on either standard or serial x-ray crystallography techniques. Fast iodide-SAD phasing for high-throughput membrane protein structure determination.,Melnikov I, Polovinkin V, Kovalev K, Gushchin I, Shevtsov M, Shevchenko V, Mishin A, Alekseev A, Rodriguez-Valera F, Borshchevskiy V, Cherezov V, Leonard GA, Gordeliy V, Popov A Sci Adv. 2017 May 12;3(5):e1602952. doi: 10.1126/sciadv.1602952. eCollection 2017, May. PMID:28508075[1] From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine. See AlsoReferences
|
| ||||||||||||||||